Actively Recruiting
Feasibility and Effectiveness of tDCS in the Treatment of Post-stroke Fatigue (EFECTS).
Led by Hospital Clinic of Barcelona · Updated on 2025-09-24
54
Participants Needed
1
Research Sites
116 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to analyze the use of non-invasive brain stimulation (tDCS) is beneficial for the treatment of post-stroke fatigue.
CONDITIONS
Official Title
Feasibility and Effectiveness of tDCS in the Treatment of Post-stroke Fatigue (EFECTS).
Who Can Participate
Eligibility Criteria
You may qualify if you...
- First stroke occurred within 38 to 52 days (45 ±7 days) from ischemic or hemorrhagic episode
- Ability to understand and follow simple instructions
- Age over 18 years
- Fatigue severity score of 24 or higher on the fatigue scale
You will not qualify if you...
- Modified Rankin Scale score greater than 2 before the stroke
- Uncontrolled heart, lung, or psychiatric conditions
- Fatigue caused by other diseases like long-term COVID
- Current or past cancer treatment
- History of epilepsy or use of antiepileptic drugs
- Diagnosis of major depression
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Clínic de Barcelona
Barcelona, Spain, Spain, 08036
Actively Recruiting
Research Team
I
Inés García-Bouyssou, PT, MsC
CONTACT
X
Xabier Urra, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here